tiletamine hydrochloride has been researched along with Eczema, Atopic in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (25.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dai, C; Gu, Y; Jiang, X; Lan, Y; Liu, X; Ma, J; Umezawa, K; Wei, B; Zhang, Y | 1 |
Gao, X; He, H; Jiang, X; Li, X; Ma, J; Ma, K; Umezawa, K; Wang, X; Xie, Z; Zhang, Y | 1 |
Abe, R; Hamasaka, A; Kishino, S; Ozaki, M; Shimizu, H; Todo, S; Umezawa, K; Yoshioka, N | 1 |
Hausen, BM; Münster, G | 1 |
4 other study(ies) available for tiletamine hydrochloride and Eczema, Atopic
Article | Year |
---|---|
External application of NF-κB inhibitor DHMEQ suppresses development of atopic dermatitis-like lesions induced with DNCB/OX in BALB/c mice.
Topics: Animals; Benzamides; Cyclohexanones; Cytokines; Dermatitis, Atopic; Dinitrochlorobenzene; Epidermis; Mice; Mice, Inbred BALB C; NF-kappa B; Ointments; Oxazolone | 2017 |
Comparison of anti-atopic dermatitis activities between DHMEQ and tacrolimus ointments in mouse model without stratum corneum.
Topics: Animals; Benzamides; Cyclohexanones; Cytokines; Dermatitis, Atopic; Dinitrochlorobenzene; Disease Models, Animal; Epidermis; Female; Humans; Immunoglobulin E; Immunosuppressive Agents; Inflammation Mediators; Mast Cells; Mice; Mice, Inbred BALB C; Ointments; Oxazolone; Tacrolimus | 2019 |
Topical application of dehydroxymethylepoxyquinomicin improves allergic inflammation via NF-kappaB inhibition.
Topics: Active Transport, Cell Nucleus; Administration, Topical; Animals; Benzamides; Cell Line; Cyclohexanones; Dermatitis, Atopic; Disease Models, Animal; Humans; Mice; NF-kappa B | 2010 |
[Cocobolo wood, a forgotten eczematogen? Recent findings on the skin allergen of cocobolo wood (Dalbergia sp.)].
Topics: Allergens; Benzoquinones; Cinnamates; Cyclohexanones; Dermatitis, Atopic; Dermatitis, Occupational; Humans; Quinones; Wood | 1983 |